BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao C, Wang D, Jiang B, Huang L, Lin T, Qiu F, Zhou S, Wang Y, Zheng X, Tian Y, Chen S. Optimization of a laparoscopic procedure for advanced intrahepatic cholangiocarcinoma based on the concept of “waiting time”: a preliminary report. BMC Cancer 2022;22:1222. [DOI: 10.1186/s12885-022-10323-x] [Reference Citation Analysis]
2 Sahakyan MA, Aghayan DL, Edwin B, Alikhanov R, Britskaia N, Brudvik KW, D’hondt M, De Meyere C, Efanov M, Fretland ÅA, Hoff R, Ismail W, Ivanecz A, Kazaryan AM, Lassen K, Magdalenić T, Parmentier I, Røsok BI, Villanger O, Yaqub S. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: a multicenter propensity score-matched study. Scandinavian Journal of Gastroenterology 2022. [DOI: 10.1080/00365521.2022.2143724] [Reference Citation Analysis]
3 Zhou Z, Guan J, Liu D, Li X, Zhang Z. Comparison of Bismuth IIIa and IIIb Types of Hilar Cholangiocarcinoma: a Multi-center Case Series Analysis of China. Indian J Surg 2022. [DOI: 10.1007/s12262-022-03589-9] [Reference Citation Analysis]
4 Chen C, Liu Z, Chen W, Wang X, Liu Y, Wang Y, Liu X, Fan H, Bai J, Jiang Y, Zhang Y, Dai H, Chen Z. Anatomical hepatectomy for achieving textbook outcome for perihilar cholangiocarcinoma treated with curative-intent resection: A multicenter study. iLIVER 2022. [DOI: 10.1016/j.iliver.2022.10.004] [Reference Citation Analysis]
5 Yue J, Miao P, Li L, Yan R, Dong W, Mei Q. Injectable Carbon Dots-Based Hydrogel for Combined Photothermal Therapy and Photodynamic Therapy of Cancer. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c15428] [Reference Citation Analysis]
6 Wang C, Ciren P, Danzeng A, Li Y, Zeng C, Zhang Z, Huang Z, Chen Y, Zhang W, Zhang B, Zhang B, Chen X. Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/4446243] [Reference Citation Analysis]
7 Nikolić I, Radić J, Petreš A, Djurić A, Protić M, Litavski J, Popović M, Kolarov-bjelobrk I, Dragin S, Popović L. The Clinical Benefit of Percutaneous Transhepatic Biliary Drainage for Malignant Biliary Tract Obstruction. Cancers 2022;14:4673. [DOI: 10.3390/cancers14194673] [Reference Citation Analysis]
8 Meng Z, Xue H, Wang T, Chen B, Dong X, Yang L, Dai J, Lou X, Xia F. Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical. J Nanobiotechnology 2022;20:344. [PMID: 35883086 DOI: 10.1186/s12951-022-01553-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Rademacher S, Denecke T, Berg T, Seehofer D. Cholangiokarzinome – intrahepatisches bis hiläres Gallengangkarzinom. Chirurgie 2022;93:644-651. [DOI: 10.1007/s00104-022-01660-5] [Reference Citation Analysis]
10 Liu JP, Lerut J, Yang Z, Li ZK, Zheng SS. Three-dimensional modeling in complex liver surgery and liver transplantation. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00130-8. [PMID: 35701284 DOI: 10.1016/j.hbpd.2022.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Vijay A, Jeon H. Liver transplantation for patients with intrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00122-9. [PMID: 35613995 DOI: 10.1016/j.hbpd.2022.05.004] [Reference Citation Analysis]
12 Nooijen LE, Banales JM, de Boer MT, Braconi C, Folseraas T, Forner A, Holowko W, Hoogwater FJH, Klümpen H, Groot Koerkamp B, Lamarca A, La Casta A, López-lópez F, Izquierdo-sánchez L, Scheiter A, Utpatel K, Swijnenburg R, Kazemier G, Erdmann JI. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers 2022;14:2389. [DOI: 10.3390/cancers14102389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jegatheeswaran S, Stathakis P, Spiers HVM, Mohammed F, Petras P, Satyadas T, Parker MJ, Lamarca A, Jamdar S, Sheen AJ, Siriwardena AK. Work-Up and Outcome of Hepatic Resection for Peri-Hilar Cholangiocarcinoma (PH-CCA) without Staging Laparoscopy. Cancers (Basel) 2022;14:1841. [PMID: 35406612 DOI: 10.3390/cancers14071841] [Reference Citation Analysis]
14 Troncone E, Gadaleta F, Paoluzi OA, Gesuale CM, Formica V, Morelli C, Roselli M, Savino L, Palmieri G, Monteleone G, Del Vecchio Blanco G. Endoscopic Ultrasound Plus Endoscopic Retrograde Cholangiopancreatography Based Tissue Sampling for Diagnosis of Proximal and Distal Biliary Stenosis Due to Cholangiocarcinoma: Results from a Retrospective Single-Center Study. Cancers (Basel) 2022;14:1730. [PMID: 35406502 DOI: 10.3390/cancers14071730] [Reference Citation Analysis]
15 D’amico FE, Mescoli C, Caregari S, Pasquale A, Billato I, Alessandris R, Lanari J, Bassi D, Boetto R, D’amico F, Vitale A, Lonardi S, Gringeri E, Cillo U. Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma. Cancers 2022;14:1680. [DOI: 10.3390/cancers14071680] [Reference Citation Analysis]
16 Inoue T, Naitoh I, Kitano R, Ibusuki M, Kobayashi Y, Sumida Y, Nakade Y, Ito K, Yoneda M. Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology 2022;29:2240-51. [DOI: 10.3390/curroncol29040182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Pavicevic S, Reichelt S, Uluk D, Lurje I, Engelmann C, Modest DP, Pelzer U, Krenzien F, Raschzok N, Benzing C, Sauer IM, Stinzing S, Tacke F, Schöning W, Schmelzle M, Pratschke J, Lurje G. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers 2022;14:1026. [DOI: 10.3390/cancers14041026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Cho MT, Gholami S, Gui D, Tejaswi SL, Fananapazir G, Abi-jaoudeh N, Jutric Z, Samarasena JB, Li X, Valerin JB, Mercer J, Dayyani F. Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach. Cancers 2022;14:392. [DOI: 10.3390/cancers14020392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, Lurje G, Pelzer U, Pratschke J, Schmelzle M, Schöning W. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach. Cancers (Basel) 2022;14:362. [PMID: 35053523 DOI: 10.3390/cancers14020362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Spolverato G, Glavas D, Hewitt DB, Brown ZJ, Capelli G, Bergamo F, Rizzato MD, Pawlik TM. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs. Expert Opin Pharmacother 2021;:1-9. [PMID: 34964678 DOI: 10.1080/14656566.2021.2020250] [Reference Citation Analysis]
21 De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ. Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med 2021;11:1270. [PMID: 34945742 DOI: 10.3390/jpm11121270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Gruttadauria S, Barbera F, Pagano D, Liotta R, Miraglia R, Barbara M, Bavetta MG, Cammà C, Petridis I, Di Carlo D, Conaldi PG, Di Francesco F. Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling. Cancers (Basel) 2021;13:6049. [PMID: 34885159 DOI: 10.3390/cancers13236049] [Reference Citation Analysis]
23 Baak R, Willemssen FEJA, van Norden Y, Eskens FALM, Milder MTW, Heijmen BJM, Koerkamp BG, Sprengers D, van Driel LMJW, Klümpen HJ, den Toom W, Koedijk MS, IJzermans JNM, Méndez Romero A. Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study. Cancers (Basel) 2021;13:3991. [PMID: 34439146 DOI: 10.3390/cancers13163991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]